Buprenorphine-Naloxone for Opioid Use Disorder: Reduction in Mortality and Increased Remission
Krishna K Paul, Christian G Frey, Stanley Troung, Laura vita Q Paglicawan, Kathryn A Cunningham, T Preston Hill, Lauren G Bothwell, Georgiy Golovko, Yeoshina Pillay, Dietrich Jehle · 2024
Read Buprenorphine-Naloxone for Opioid Use Disorder: Reduction in Mortality and Increased Remission by Krishna K Paul, Christian G Frey, Stanley Troung, Laura vita Q Paglicawan, Kathryn A Cunningham, T Preston Hill, Lauren G Bothwell, Georgiy Golovko, Yeoshina Pillay, Dietrich Jehle (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11610725.txt.
Description
IntroductionAs fentanyl has become more readily available, opioid-related morbidity and mortality in the United States has increased dramatically. Preliminary studies suggest that high-affinity, partial mu-opioid receptor agonists such as the combination product buprenorphine-naloxone may reduce mortality from overdose and promote remission.
Catalog record
| CREATOR | Krishna K Paul, Christian G Frey, Stanley Troung, Laura vita Q Paglicawan, Kathryn A Cunningham, T Preston Hill, Lauren G Bothwell, Georgiy Golovko, Yeoshina Pillay, Dietrich Jehle |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |